EGFR and colorectal cancer: A pre-clinical trial of Anti-EGFR antibody cetuximab (C255) approved by FDA for the treatment of EGFR – positive colorectal cancer and palladium compound (TOOKAD) is a clinical trial by photo-dynamic therapy for the treatment of prostate cancer (65).